WCM
VIVO

Wedge Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Wedge Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-101,537
Closed -$2.37M – 566
2020
Q2 		$2.37M Buy
101,537
+70,584
+228% +$1.02M 0.03% 263
2020
Q1 		$260K Buy
30,953
+4,433
+17% +$37.3K ﹤0.01% 423
2019
Q4 		$259K Buy
26,520
+1,497
+6% +$14.1K ﹤0.01% 499
2019
Q3 		$237K Sell
25,023
-16,457
-40% -$173K ﹤0.01% 517
2019
Q2 		$493K Buy
+41,480
New +$500K 0.01% 459

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wedge Capital Management's VIVO Position: Q3 2020 in Review

Wedge Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2020, closing a stake of 101,537 shares — an estimated $2.37M sold.

Wedge Capital Management first reported a position in VIVO in Q2 2019 and held it in 5 quarters. The position peaked at $2.37M in Q2 2020. 191 funds tracked by Wall St. Rank hold VIVO as of Q3 2020.

  • Wedge Capital Management reported no remaining Meridian Bioscience Inc position as of Q3 2020 after selling out during the quarter.
  • Wedge Capital Management sold 101,537 Meridian Bioscience Inc shares in Q3 2020, an estimated $2.37M.
  • Wedge Capital Management first reported a position in Meridian Bioscience Inc in Q2 2019 and held it in 5 quarters.
  • Wedge Capital Management's Meridian Bioscience Inc position peaked at $2.37M in Q2 2020.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2020.

Based on Wedge Capital Management's 13F filing for Q3 2020, filed 8 Oct 2020.